查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1684680

攜帶式血紅素分析儀市場機會、成長動力、產業趨勢分析及 2025 - 2034 年預測

Portable Hemoglobin Analyzers Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025 - 2034
出版日期: | 出版商: Global Market Insights Inc. | 英文 145 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

2024 年全球攜帶式血紅素分析儀市值為 3.597 億美元，預計在 2025 年至 2034 年期間以 5% 的複合年成長率穩步成長。對可獲取、快速和準確的診斷解決方案的需求不斷成長，凸顯了攜帶式血紅蛋白分析儀在現代醫療保健中日益成長的重要性。隨著人們對醫療保健問題的認知不斷提高，即時檢測設備的採用也在不斷增加，這些設備可以增強醫療保健提供者的能力並改善患者的治療效果。這些分析儀為滿足城市和偏遠地區人口的診斷需求提供了重要工具，彌補了全球醫療保健基礎設施的關鍵空白。

攜帶式血紅素分析儀市場 - IMG1

貧血仍然是全球普遍的健康挑戰，影響著數十億人，特別是婦女、兒童和老年人。攜帶式血紅素分析儀提供了重要的解決方案，可提供快速可靠的結果，支持早期診斷和及時介入。該設備的便攜性和易用性使其成為無法使用傳統實驗室設施的醫療服務不足和偏遠地區的必備設備。世界各國政府和醫療保健組織日益提倡早期發現和有效管理貧血，特別是在醫療基礎設施不足的地區。對增強診斷能力的推動極大地增強了對攜帶式血紅蛋白分析儀的需求，有助於改善醫療保健的機會和公平性。

市場範圍
起始年份 2024
預測年份 2025-2034
起始值 3.597 億美元
預測值 5848億美元
複合年成長率 5％

市場分為兩種主要產品類型：手持式分析儀和桌上型分析儀。 2024年，手持式分析儀創造了2.027億美元的收入，鞏固了其作為領先領域的地位。它們設計緊湊、價格實惠且具有方便用戶使用功能，特別適合鄉村診所、急診室和家庭醫療保健環境等即時護理場所。手持式分析儀提供的快速、精確的結果對於醫療保健提供者管理貧血和其他相關疾病至關重要，凸顯了它們在現代診斷中的關鍵作用。

攜帶式血紅素分析儀的應用包括貧血診斷、慢性病監測和其他用途。貧血診斷領域預計將達到最高成長，複合年成長率為 5.2%，到 2034 年將達到 3.4 億美元。攜帶式血紅素分析儀在促進早期檢測和管理方面發揮著變革性的作用，這對於改善健康結果至關重要。它們的重要性遍及已開發地區和發展中地區，貧血在這些地區仍然是一個重大的公共衛生問題，凸顯了這些設備的全球相關性。

在美國，攜帶式血紅素分析儀市場在 2024 年的價值為 1.338 億美元，預計到 2034 年將以 4.4% 的複合年成長率成長。貧血的流行，特別是在婦女、兒童和老年人中，持續推動對可靠診斷解決方案的需求。攜帶式血紅素分析儀可以滿足這一需求，提供快速有效的結果，實現及時的醫療干預，並為全國各地的患者提供更好的健康結果。

目錄

第 1 章：方法論與範圍

第 2 章：執行摘要

第 3 章：產業洞察

  • 產業生態系統分析
  • 產業衝擊力
    • 成長動力
      • 貧血和其他血液疾病盛行率上升
      • 即時診斷檢測的需求不斷增加
      • 攜帶式醫療設備和技術的進步
      • 越來越重視早期診斷和預防保健
    • 產業陷阱與挑戰
      • 偏遠和低度開發地區的可用性有限
      • 與攜帶式設備的準確性和可靠性相關的問題
  • 成長潛力分析
  • 2024 年定價分析
  • 監管格局
  • 技術格局
  • 差距分析
  • 波特的分析
  • PESTEL 分析
  • 價值鏈分析

第4章：競爭格局

  • 介紹
  • 公司矩陣分析
  • 公司市佔率分析
  • 主要市場參與者的競爭分析
  • 競爭定位矩陣
  • 策略儀表板

第 5 章：市場估計與預測：按產品類型，2021 年至 2034 年

  • 主要趨勢
  • 手持式分析儀
  • 桌上型分析儀

第6章：市場估計與預測：按技術，2021 – 2034 年

  • 主要趨勢
  • 光度分析
  • 基於色譜法
  • 電化學檢測
  • 其他技術

第 7 章：市場估計與預測：按應用，2021 年至 2034 年

  • 主要趨勢
  • 貧血診斷
  • 慢性疾病監測
  • 其他應用

第 8 章：市場估計與預測：依最終用途，2021 年至 2034 年

  • 主要趨勢
  • 醫院
  • 診斷實驗室
  • 其他最終用戶

第 9 章：市場估計與預測：按配銷通路，2021 年至 2034 年

  • 主要趨勢
  • 實體店面
  • 電子商務

第 10 章：市場估計與預測：按地區，2021 年至 2034 年

  • 主要趨勢
  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 西班牙
    • 義大利
    • 荷蘭
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 澳洲
    • 韓國
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國

第 11 章：公司簡介

  • EKF
  • Abbott
  • ACON
  • Arkray
  • BeneCheck
  • BioHermes Bio & Medical Tech
  • boditech
  • cnoga
  • HemoCue
  • Horiba Medical
  • nova
  • SENSA CORE
  • SIEMENS Healthineers
  • Trinity Biotech
  • URIT
簡介目錄
Product Code: 13096

The Global Portable Hemoglobin Analyzers Market, valued at USD 359.7 million in 2024, is poised for steady growth at a CAGR of 5% from 2025 to 2034. This growth trajectory is driven by the escalating prevalence of anemia and other hemoglobin-related health conditions worldwide. The rising demand for accessible, rapid, and accurate diagnostic solutions underscores the increasing importance of portable hemoglobin analyzers in modern healthcare. As awareness of healthcare issues grows, so does the adoption of point-of-care testing devices that empower healthcare providers and enhance patient outcomes. These analyzers offer an essential tool for addressing the diagnostic needs of both urban and remote populations, bridging critical gaps in global healthcare infrastructure.

Portable Hemoglobin Analyzers Market - IMG1

Anemia continues to be a pervasive global health challenge, affecting billions of individuals, particularly women, children, and elderly populations. Portable hemoglobin analyzers provide a vital solution, delivering quick and reliable results that support early diagnosis and timely intervention. The devices' portability and ease of use make them indispensable in underserved and remote areas where access to traditional laboratory facilities is limited. Governments and healthcare organizations worldwide are increasingly advocating for early detection and effective management of anemia, particularly in regions with inadequate medical infrastructure. This push for enhanced diagnostic capabilities has significantly bolstered the demand for portable hemoglobin analyzers, contributing to improved healthcare access and equity.

Market Scope
Start Year2024
Forecast Year2025-2034
Start Value$359.7 Million
Forecast Value$584.8 Billion
CAGR5%

The market is categorized into two primary product types: handheld analyzers and benchtop analyzers. In 2024, handheld analyzers generated USD 202.7 million in revenue, solidifying their position as the leading segment. Their compact design, affordability, and user-friendly features make them particularly suited for point-of-care settings such as rural clinics, emergency rooms, and home healthcare environments. The rapid and precise results provided by handheld analyzers are instrumental for healthcare providers managing anemia and other related conditions, underscoring their critical role in modern diagnostics.

Applications of portable hemoglobin analyzers span anemia diagnosis, chronic disease monitoring, and other uses. The anemia diagnosis segment is expected to achieve the highest growth, with a CAGR of 5.2%, and reach USD 340 million by 2034. This robust growth is fueled by the rising incidence of anemia across the globe, especially in vulnerable populations. Portable hemoglobin analyzers play a transformative role in facilitating early detection and management, which is crucial for improving health outcomes. Their importance extends across both developed and developing regions, where anemia persists as a significant public health issue, underscoring the global relevance of these devices.

In the United States, the portable hemoglobin analyzers market was valued at USD 133.8 million in 2024 and is anticipated to grow at a CAGR of 4.4% through 2034. The U.S. remains a pivotal market for these devices, supported by a robust healthcare system and an increasing emphasis on preventive care. The prevalence of anemia, particularly among women, children, and older adults, continues to drive the demand for reliable diagnostic solutions. Portable hemoglobin analyzers address this need by offering quick and efficient results, enabling timely medical interventions, and fostering better health outcomes for patients across the country.

Table of Contents

Chapter 1 Methodology and Scope

  • 1.1 Market scope and definitions
  • 1.2 Research design
    • 1.2.1 Research approach
    • 1.2.2 Data collection methods
  • 1.3 Base estimates and calculations
    • 1.3.1 Base year calculation
    • 1.3.2 Key trends for market estimation
  • 1.4 Forecast model
  • 1.5 Primary research and validation
    • 1.5.1 Primary sources
    • 1.5.2 Data mining sources

Chapter 2 Executive Summary

  • 2.1 Industry 3600 synopsis

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Rising prevalence of anemia and other blood disorders
      • 3.2.1.2 Increasing demand for point-of-care testing
      • 3.2.1.3 Advancements in portable medical devices and technology
      • 3.2.1.4 Growing focus on early diagnosis and preventive healthcare
    • 3.2.2 Industry pitfalls and challenges
      • 3.2.2.1 Limited availability in remote and underdeveloped areas
      • 3.2.2.2 Issues related to the accuracy and reliability of portable devices
  • 3.3 Growth potential analysis
  • 3.4 Pricing analysis, 2024
  • 3.5 Regulatory landscape
  • 3.6 Technology landscape
  • 3.7 Gap analysis
  • 3.8 Porter's analysis
  • 3.9 PESTEL analysis
  • 3.10 Value chain analysis

Chapter 4 Competitive Landscape, 2024

  • 4.1 Introduction
  • 4.2 Company matrix analysis
  • 4.3 Company market share analysis
  • 4.4 Competitive analysis of major market players
  • 4.5 Competitive positioning matrix
  • 4.6 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Product Type, 2021 – 2034 ($ Mn)

  • 5.1 Key trends
  • 5.2 Handheld analyzers
  • 5.3 Benchtop analyzers

Chapter 6 Market Estimates and Forecast, By Technology, 2021 – 2034 ($ Mn)

  • 6.1 Key trends
  • 6.2 Photometric analysis
  • 6.3 Chromatography-based
  • 6.4 Electrochemical detection
  • 6.5 Other technologies

Chapter 7 Market Estimates and Forecast, By Application, 2021 – 2034 ($ Mn)

  • 7.1 Key trends
  • 7.2 Anemia diagnosis
  • 7.3 Chronic disease monitoring
  • 7.4 Other applications

Chapter 8 Market Estimates and Forecast, By End Use, 2021 – 2034 ($ Mn)

  • 8.1 Key trends
  • 8.2 Hospital
  • 8.3 Diagnostic laboratories
  • 8.4 Other end users

Chapter 9 Market Estimates and Forecast, By Distribution Channel, 2021 – 2034 ($ Mn)

  • 9.1 Key trends
  • 9.2 Brick and mortar
  • 9.3 E-commerce

Chapter 10 Market Estimates and Forecast, By Region, 2021 – 2034 ($ Mn)

  • 10.1 Key trends
  • 10.2 North America
    • 10.2.1 U.S.
    • 10.2.2 Canada
  • 10.3 Europe
    • 10.3.1 Germany
    • 10.3.2 UK
    • 10.3.3 France
    • 10.3.4 Spain
    • 10.3.5 Italy
    • 10.3.6 Netherlands
  • 10.4 Asia Pacific
    • 10.4.1 China
    • 10.4.2 Japan
    • 10.4.3 India
    • 10.4.4 Australia
    • 10.4.5 South Korea
  • 10.5 Latin America
    • 10.5.1 Brazil
    • 10.5.2 Mexico
    • 10.5.3 Argentina
  • 10.6 Middle East and Africa
    • 10.6.1 South Africa
    • 10.6.2 Saudi Arabia
    • 10.6.3 UAE

Chapter 11 Company Profiles

  • 11.1 EKF
  • 11.2 Abbott
  • 11.3 ACON
  • 11.4 Arkray
  • 11.5 BeneCheck
  • 11.6 BioHermes Bio & Medical Tech
  • 11.7 boditech
  • 11.8 cnoga
  • 11.9 HemoCue
  • 11.10 Horiba Medical
  • 11.11 nova
  • 11.12 SENSA CORE
  • 11.13 SIEMENS Healthineers
  • 11.14 Trinity Biotech
  • 11.15 URIT